D84 D80 D81 D82 D83
Conditions
Interventions
Group 1: Baseline documentation: Age, sex, familial cases, first symptoms, diagnosis, haemtopoietic stem cell transplantation (HSCT), immunoglobulin replacement (Ig replacement), lab values, clinical
Yearly follow-up: living status, therapy status (HSCT, Ig replacement), changes to diagnosis, lab values, clinical features
Sponsors
European Society for Immunodeficiencies (ESID)c/o Kenes Education B.V.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of a primary immunodeficiency
Exclusion criteria
Exclusion criteria: Diagnosis of a secondary immunodeficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine the epidemiology of primary immunodeficiencies (PID) | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of clinical features, life expectancy, complications, medication effects | — |
Countries
Austria, Belgium, Croatia, Czechia, Egypt, France, Germany, Hungary, Iran, Ireland, Israel, Italy, Netherlands, Poland, Slovakia, Slovenia, Spain, Switzerland, United Kingdom
Contacts
Public ContactMarkus Seidel
Universität Graz, Österreich
Outcome results
None listed